Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA with Low-Dose Chemotherapy in Older NPM1-Mutated AML Patients
NCT01237808Phase 3Completed
- Sponsor
- Ulm University
- Start
- Mar 2011
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tretinoin in acute myeloid leukemia (AML), sponsored by Ulm University. Started Mar 2011; status: completed.
02
Drugs
tretinoin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01237808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01237808.